| SCHEDULE OF FAIR VALUE OF CONSIDERATION TRANSFERRED ASSETS ACQUIRED LIABILITIES ASSUMED |
SCHEDULE OF FAIR VALUE OF CONSIDERATION TRANSFERRED ASSETS ACQUIRED LIABILITIES ASSUMED
Table
8: SLG Valuation
| | |
Initial
Allocation of Assets and Liabilities | | |
Adjustments | | |
Estimated
Allocation of Assets and Liabilities as of September 30, 2025 | |
| Cash
consideration: | |
| | | |
| | | |
| | |
| Cash consideration | |
$ | 2,000,000 | | |
$ | - | | |
$ | 2,000,000 | |
| Less:
cash acquired | |
| (34,983 | ) | |
| - | | |
| (34,983 | ) |
| Cash consideration, net
of cash acquired | |
| 1,965,017 | | |
| - | | |
| 1,965,017 | |
| Noncash consideration: | |
| | | |
| - | | |
| | |
| Common stock (1) | |
| 254,071 | | |
| 250,071 | | |
| 504,142 | |
| Series E Convertible Preferred
Stock (2) | |
| 255,000 | | |
| - | | |
| 255,000 | |
| Accounts
receivable in Cycurion owing from SLG (3) | |
| 10,814,147 | | |
| - | | |
| 10,814,147 | |
| Noncash
consideration | |
| 11,323,218 | | |
| 250,071 | | |
| 11,573,289 | |
| Total
consideration | |
$ | 13,288,235 | | |
$ | 250,071 | | |
$ | 13,538,306 | |
| Assets
acquired: | |
| | | |
| | | |
| | |
| Accounts
receivable | |
$ | 3,066,581 | | |
$ | - | | |
$ | 3,066,581 | |
| Total
identified assets acquired | |
| 3,066,581 | | |
| - | | |
| 3,066,581 | |
| Liabilities
assumed: | |
| | | |
| | | |
| | |
| Accounts payable | |
| 4,317,052 | | |
| - | | |
| 4,317,052 | |
| Accrued liabilities | |
| 10,650 | | |
| 54,209 | | |
| 64,859 | |
| Payroll liability | |
| 40,642 | | |
| - | | |
| 40,642 | |
| Factoring liability | |
| 2,176,922 | | |
| - | | |
| 2,176,922 | |
| Due to related parties | |
| 18,000 | | |
| - | | |
| 18,000 | |
| Loans payable | |
| 625,222 | | |
| - | | |
| 625,222 | |
| Liabilities
to Cycurion | |
| 2,982,908 | | |
| - | | |
| 2,982,908 | |
| Total
identified liabilities assumed | |
| 10,171,396 | | |
| 54,209 | | |
| 10,225,605 | |
| Net identifiable liabilities
assumed | |
| (7,104,815 | ) | |
| (54,209 | ) | |
| (7,159,024 | ) |
| Elimination of inter-company
balances | |
| 2,982,908 | | |
| - | | |
| 2,982,908 | |
| Non-controlling interest | |
| (3,464,218 | ) | |
| - | | |
| (3,464,218 | ) |
| Goodwill | |
| 13,945,924 | | |
| 304,280 | | |
| 14,250,204 | |
| Net assets acquired | |
$ | 13,288,235 | | |
$ | 250,071 | | |
$ | 13,538,306 | |
| |
(1) |
Represents the fair value of 33,609 common stock issued in
the SLG transaction based on the quoted stock price on the date of issuance. |
| |
(2) |
Represents the fair value of the Series E Convertible Preferred
Stock as is converted to common stock based on the quoted price common stock on the date of issuance. |
| |
(3) |
Represents the fair value of the accounts receivable in Cycurion
owing from SLG. |
| |
(4) |
Fair value of the noncontrolling interest based on NCI’s
49% interest in the net assets acquired. |
| |
(5) |
Goodwill is calculated as Total Consideration paid less the
net assets acquired. |
|
| SCHEDULE OF LOAN PAYABLE AND ADVANCES |
SCHEDULE OF LOAN PAYABLE AND ADVANCES
Table 11:
Details of Loans Payable
| | |
September
30, 2025 | | |
December
31, 2024 | |
| Loan payable | |
$ | 405,314 | | |
$ | 405,314 | |
| Loan payable - SLG | |
| 264,379 | | |
| - | |
| Economic injury disaster loan - Cycurion | |
| 150,000 | | |
| 150,000 | |
| Economic injury disaster loan - SLG | |
| 157,220 | | |
| - | |
| Private loan payable | |
| 203,623 | | |
| - | |
| Funded loans payable | |
| 1,180,536 | | |
| 555,314 | |
| Less: Unamortized debt-issuance
costs and discounts | |
| - | | |
| - | |
| Total loans payable | |
| 1,180,536 | | |
| 555,314 | |
| Less: Current portion
of long-term debt | |
| 885,240 | | |
| 408,516 | |
| Long-term debt | |
$ | 295,296 | | |
$ | 146,798 | |
|